Munich, Germany

Stefan Kiesewetter

This inventor holds 1 USPTO granted patent. Top assignee: Fraunhofer. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan Kiesewetter. Retrieved from https://idiyas.com/inventor/stefan-kiesewetter-a4elr6ek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stefan Kiesewetter

Introduction

Stefan Kiesewetter is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biochemistry, particularly through his innovative work on ribonucleotide polypeptides. His research has implications for the development of new medicaments and therapeutic applications.

Latest Patents

Stefan Kiesewetter holds a patent for "Metal-containing ribonucleotide polypeptides." This invention relates to the production and use of metal-containing ribonucleotide polypeptides (RNP) and their molecular-biological equivalent structures, parts, and derivatives. The patent highlights the potential applications of these compounds in medicinal formulations.

Career Highlights

Kiesewetter is associated with the Fraunhofer Society, a leading research institution in Germany. His work at Fraunhofer has allowed him to explore advanced biotechnological solutions and contribute to the scientific community through his innovative research.

Collaborations

Stefan Kiesewetter has collaborated with esteemed colleagues such as Eckehard Kuhn and Bridgitte Koch-Pelster. These partnerships have fostered a collaborative environment that enhances the research and development of new technologies in the field.

Conclusion

Stefan Kiesewetter's contributions to the field of biochemistry through his patent on metal-containing ribonucleotide polypeptides exemplify the innovative spirit of modern science. His work continues to pave the way for advancements in medicinal applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…